rs3092902

Variant summary

Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_ModerateBP6_Very_StrongBS2

The NM_000321.3(RB1):​c.411A>T​(p.Glu137Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000684 in 1,612,608 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00039 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00071 ( 1 hom. )

Consequence

RB1
NM_000321.3 missense

Scores

10
9

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts U:1B:12

Conservation

PhyloP100: 2.55
Variant links:
Genes affected
RB1 (HGNC:9884): (RB transcriptional corepressor 1) The protein encoded by this gene is a negative regulator of the cell cycle and was the first tumor suppressor gene found. The encoded protein also stabilizes constitutive heterochromatin to maintain the overall chromatin structure. The active, hypophosphorylated form of the protein binds transcription factor E2F1. Defects in this gene are a cause of childhood cancer retinoblastoma (RB), bladder cancer, and osteogenic sarcoma. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -14 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.16841224).
BP6
Variant 13-48345110-A-T is Benign according to our data. Variant chr13-48345110-A-T is described in ClinVar as [Likely_benign]. Clinvar id is 41684.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 59 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RB1NM_000321.3 linkc.411A>T p.Glu137Asp missense_variant Exon 4 of 27 ENST00000267163.6 NP_000312.2 P06400A0A024RDV3
RB1NM_001407165.1 linkc.411A>T p.Glu137Asp missense_variant Exon 4 of 27 NP_001394094.1
RB1NM_001407166.1 linkc.411A>T p.Glu137Asp missense_variant Exon 4 of 17 NP_001394095.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RB1ENST00000267163.6 linkc.411A>T p.Glu137Asp missense_variant Exon 4 of 27 1 NM_000321.3 ENSP00000267163.4 P06400
RB1ENST00000467505.5 linkn.138-14907A>T intron_variant Intron 1 of 2 1 ENSP00000434702.1 Q92728
RB1ENST00000650461.1 linkc.411A>T p.Glu137Asp missense_variant Exon 4 of 27 ENSP00000497193.1 A0A3B3IS71
RB1ENST00000525036.1 linkn.573A>T non_coding_transcript_exon_variant Exon 4 of 7 3

Frequencies

GnomAD3 genomes
AF:
0.000388
AC:
59
AN:
152204
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000941
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000823
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000335
AC:
84
AN:
250512
Hom.:
0
AF XY:
0.000413
AC XY:
56
AN XY:
135470
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000187
Gnomad NFE exome
AF:
0.000671
Gnomad OTH exome
AF:
0.000655
GnomAD4 exome
AF:
0.000715
AC:
1044
AN:
1460404
Hom.:
1
Cov.:
31
AF XY:
0.000718
AC XY:
522
AN XY:
726570
show subpopulations
Gnomad4 AFR exome
AF:
0.000120
Gnomad4 AMR exome
AF:
0.0000224
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.000113
Gnomad4 NFE exome
AF:
0.000908
Gnomad4 OTH exome
AF:
0.000398
GnomAD4 genome
AF:
0.000388
AC:
59
AN:
152204
Hom.:
0
Cov.:
32
AF XY:
0.000296
AC XY:
22
AN XY:
74358
show subpopulations
Gnomad4 AFR
AF:
0.0000241
Gnomad4 AMR
AF:
0.0000654
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.0000941
Gnomad4 NFE
AF:
0.000823
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000507
Hom.:
0
Bravo
AF:
0.000329
TwinsUK
AF:
0.000809
AC:
3
ALSPAC
AF:
0.000778
AC:
3
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00105
AC:
9
ExAC
AF:
0.000412
AC:
50
EpiCase
AF:
0.000600
EpiControl
AF:
0.000593

ClinVar

Significance: Benign/Likely benign
Submissions summary: Uncertain:1Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:4
Sep 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

RB1: BP4 -

Jul 13, 2012
Biesecker Lab/Clinical Genomics Section, National Institutes of Health
Significance: Uncertain significance
Review Status: no assertion criteria provided
Collection Method: research

- -

Apr 07, 2020
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Dec 13, 2022
Mendelics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Mar 22, 2021
GeneDx
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is associated with the following publications: (PMID: 27153395, 15776430, 9311732, 15884040, 26933808, 25742471, 23810757, 27600092, 16546179, 20596833, 7981694, 7795591, 22703879, 17996702, 8364580) -

Retinoblastoma Benign:4
May 20, 2024
Genetic Diagnostic Laboratory, University of Pennsylvania School of Medicine
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Case and Pedigree Information: BILATERAL CASES:0, UNILATERAL CASES:1, TOTAL CASES:1, PEDIGREES:1. ACMG Codes Applied:BS1, BP6 -

Oct 09, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. -

Jan 28, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Apr 26, 2022
Color Diagnostics, LLC DBA Color Health
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Hereditary cancer-predisposing syndrome Benign:2
Oct 21, 2020
Sema4, Sema4
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: curation

- -

Aug 27, 2018
Ambry Genetics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

RB1-related disorder Benign:1
Nov 16, 2021
PreventionGenetics, part of Exact Sciences
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Malignant tumor of urinary bladder;C0035335:Retinoblastoma;C0149925:Small cell lung carcinoma;C0585442:Bone osteosarcoma Benign:1
Feb 11, 2025
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.11
T
BayesDel_noAF
Uncertain
0.0
CADD
Benign
22
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.45
T;.
Eigen
Uncertain
0.28
Eigen_PC
Uncertain
0.24
FATHMM_MKL
Uncertain
0.81
D
LIST_S2
Benign
0.71
T;T
M_CAP
Benign
0.046
D
MetaRNN
Benign
0.17
T;T
MetaSVM
Uncertain
-0.082
T
MutationAssessor
Benign
1.9
L;.
PrimateAI
Uncertain
0.56
T
PROVEAN
Benign
-1.3
N;.
REVEL
Uncertain
0.60
Sift
Benign
0.031
D;.
Sift4G
Uncertain
0.059
T;.
Polyphen
0.96
D;.
Vest4
0.32
MutPred
0.65
Gain of catalytic residue at T142 (P = 0.0465);Gain of catalytic residue at T142 (P = 0.0465);
MVP
0.90
MPC
1.2
ClinPred
0.11
T
GERP RS
4.7
Varity_R
0.25
gMVP
0.35

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs3092902; hg19: chr13-48919246; COSMIC: COSV57295791; COSMIC: COSV57295791; API